Concord-Carlisle High School students designed and built hydraulic robotic arms, showcasing their engineering skills.

The number and variety of test interfaces, coupled with increased packaging complexity, are adding a slew of new challenges.

BMW’s latest M4 Coupe is limited to just 40 units and celebrates the 40th anniversary of the original M3. The 2027 M4 Coupe M Legacy Edition celebrates 40 years since the M3 Coupe debuted. Only 40 ...

Last month Perplexity announced the confusingly named “Computer,” its cloud-based agent tool for completing tasks using a harness that makes use of multiple different AI models. This week, the company ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Personal Computer is designed to be your personal assistant with access to all your tools It's ...

After teasing a plasma-based manufacturing expansion in the U.S. late last year, CSL is putting in the work and firming up details behind the $1.5 billion project. Monday, the Australian biopharma ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

The CSL Ltd (ASX: CSL) share price is 2% higher at $145.71 a piece in Thursday morning trade. At the time of writing, the beaten-down biotech stock is down 15.24% year to date and 44.85% over the year ...

When the 2026 Chinese Super League (CSL) season kicks off on Friday with Chengdu Rongcheng hosting Shenzhen Peng City in Southwest China's Sichuan Province, it will be under a cloud of uncertainty and ...

Eli Lilly has been scouting for drugs to follow the trail blazed by its blockbuster cardiometabolic medicines. Its latest pipeline-building deal has the pharmaceutical company paying $100 million for ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...

CSL announced the exit of Paul McKenzie as chief executive. Senior executive Gordon Naylor appointed interim CEO. Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it ...